Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China

被引：0
作者：
Huang, Kun [1 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Dept Pediat, Sch Med, 1367 Wenyi West Rd, Hangzhou 311121, Zhejiang, Peoples R China
来源：
ADVANCES IN THERAPY | 2024年 / 41卷 / 04期
关键词：
Hemophilia A; Pharmacokinetics; Cost-effectiveness; Prophylaxis; Bleeding;
D O I：
10.1007/s12325-024-02786-0
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1759 / 1761
页数：3
相关论文
共 50 条
[21]   Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis [J].
Adibi, Mehrad ;
Pearle, Margaret S. ;
Lotan, Yair .
BJU INTERNATIONAL, 2012, 110 (2B) :E86-E91
[22]   The Impact of Pharmacokinetic-Guided Prophylaxis on Clinical Outcomes and Healthcare Resource Utilization in Hemophilia A Patients: Real-World Evidence from the CHESS II Study [J].
Grazzi, Enrico Ferri ;
Sun, Shawn X. ;
Burke, Tom ;
O'Hara, Jamie .
JOURNAL OF BLOOD MEDICINE, 2022, 13 :505-516
[23]   Cefuroxime (Aprokam®) in the Prophylaxis of Postoperative Endophthalmitis After Cataract Surgery Versus Absence of Antibiotic Prophylaxis: A Cost-Effectiveness Analysis in Poland [J].
Rekas, Marek ;
Mlynczak, Katarzyna ;
Dobrowolska, Iwona ;
Niewada, Maciej ;
Golicki, Dominik .
VALUE IN HEALTH REGIONAL ISSUES, 2020, 22 :115-121
[24]   PK-driven prophylaxis versus standard prophylaxis: When a tailored treatment may be a real and achievable cost-saving approach in children with severe hemophilia A [J].
Pasca, Samantha ;
Milan, Marta ;
Sarolo, Lucia ;
Zanon, Ezio .
THROMBOSIS RESEARCH, 2017, 157 :58-63
[25]   Revisiting the cost-effectiveness of primary prophylaxis with clotting factor for the treatment of severe haemophilia A [J].
Miners, A. .
HAEMOPHILIA, 2009, 15 (04) :881-887
[26]   Cost-effectiveness analysis of late prophylaxis vs. on-demand treatment for severe haemophilia A in Italy [J].
Coppola, A. ;
D'Ausilio, A. ;
Aiello, A. ;
Amoresano, S. ;
Toumi, M. ;
Mathew, P. ;
Tagliaferri, A. .
HAEMOPHILIA, 2017, 23 (03) :422-429
[27]   Cost-effectiveness analysis of the use of palivizumab in the prophylaxis of preterm patients in Mexico [J].
Salinas-Escudero, Guillermo ;
Martinez-Valverde, Silvia ;
Reyes-Lopez, Alfonso ;
Garduno-Espinosa, Juan ;
Munoz-Hernandez, Onofre ;
Granados-Garcia, Victor ;
Rely, Kely .
SALUD PUBLICA DE MEXICO, 2012, 54 (01) :47-59
[28]   Cost-effectiveness analysis of HIV pre-exposure prophylaxis in Japan [J].
Mizushima, Daisuke ;
Nagai, Yoshino ;
Mezzio, Dylan ;
Harada, Keisuke ;
Piao, Yi ;
Barnieh, Lianne ;
El Moustaid, Fadoua ;
Cawson, Matthew ;
Taniguchi, Toshibumi .
JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) :886-893
[29]   Antibiotic prophylaxis at the time of dental implant placement: a cost-effectiveness analysis [J].
Khrystyna Zhurakivska ;
Lucio Lo Russo ;
Lorenzo Lo Muzio ;
Vito Carlo Alberto Caponio ;
Luigi Laino ;
Claudia Arena ;
Nicola Cirillo ;
Giuseppe Troiano .
BMC Health Services Research, 22
[30]   Antibiotic prophylaxis at the time of dental implant placement: a cost-effectiveness analysis [J].
Zhurakivska, Khrystyna ;
Lo Russo, Lucio ;
Lo Muzio, Lorenzo ;
Caponio, Vito Carlo Alberto ;
Laino, Luigi ;
Arena, Claudia ;
Cirillo, Nicola ;
Troiano, Giuseppe .
BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
12345